Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › ERK1 and ERK2 mutations that confer resistance to MAPK pathway inhibitors

ERK1 and ERK2 mutations that confer resistance to MAPK pathway inhibitors

US Patent 11186874 · Granted Nov 30, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

C-RAF mutants that confer resistance to RAF inhibitors2024
Compositions and methods for treating ovarian tumors2024
C-RAF mutants that confer resistance to RAF inhibitors2023
MEK1 mutation conferring resistance to RAF and MEK inhibitors2023
Methods of diagnosing and treating cancer in patients having or developing resis2021
Methods of identifying responses to map kinase inhibition therapy2021
MEK1 mutation conferring resistance to RAF and MEK inhibitors2020
MEK1 mutation conferring resistance to RAF and MEK inhibitors2018
C-RAF mutants that confer resistance to RAF inhibitors2017
Compositions and methods of treating head and neck cancer2016
Screening method for BRAF inhibitors2016
MEK mutations conferring resistance to MEK inhibitors2015